Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 369 entries
Sorted by: Best Match Show Resources per page
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.

Breast care (Basel, Switzerland)

Jackisch C, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, Marschner N, Möbus V, Scheithauer H, Schneeweiss A, Thomssen C, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Fasching PA, Fehm T, Janni W, Lück HJ, Maass N, Scharl A, Untch M.
PMID: 26557827
Breast Care (Basel). 2015 Jul;10(3):211-9. doi: 10.1159/000433590. Epub 2015 Jun 23.

The key topics of this year's 14th St. Gallen Consensus Conference on the diagnosis and therapy of primary breast cancer were again questions about breast surgery and axillary surgery, radio-oncology and systemic therapy options in consideration of tumor biology,...

Cite
Jackisch C, Harbeck N, Huober J, et al. 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast Care (Basel). 2015;10(3):211-9doi: 10.1159/000433590.
Jackisch, C., Harbeck, N., Huober, J., von Minckwitz, G., Gerber, B., Kreipe, H. H., Liedtke, C., Marschner, N., Möbus, V., Scheithauer, H., Schneeweiss, A., Thomssen, C., Loibl, S., Beckmann, M. W., Blohmer, J. U., Costa, S. D., Decker, T., Diel, I., Fasching, P. A., Fehm, T., Janni, W., Lück, H. J., Maass, N., Scharl, A., & Untch, M. (2015). 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast care (Basel, Switzerland), 10(3), 211-9. https://doi.org/10.1159/000433590
Jackisch, Christian, et al. "14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts." Breast care (Basel, Switzerland) vol. 10,3 (2015): 211-9. doi: https://doi.org/10.1159/000433590
Jackisch C, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, Marschner N, Möbus V, Scheithauer H, Schneeweiss A, Thomssen C, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Fasching PA, Fehm T, Janni W, Lück HJ, Maass N, Scharl A, Untch M. 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast Care (Basel). 2015 Jul;10(3):211-9. doi: 10.1159/000433590. Epub 2015 Jun 23. PMID: 26557827; PMCID: PMC4569213.
Copy Download .nbib Format: NLM
Clinical validation of genetic variants associated with .

Oncotarget

Fasching PA, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, Lux MP, Cunningham JM, Ruebner M, Jenkins G, Fridley B, Schneeweiss A, Tesch H, Lichtenegger W, Fehm T, Heinrich G, Rezai M, Beckmann MW, Janni W, Weinshilboum RM, Wang L.
PMID: 29100455
Oncotarget. 2017 May 09;8(44):78133-78143. doi: 10.18632/oncotarget.17726. eCollection 2017 Sep 29.

Hematotoxicity is one of the major side effects of chemotherapy. The aim of this study was to examine the association between single nucleotide polymorphisms (SNPs) and hematotoxicity in breast cancer patients in a subset of patients of the SUCCESS...

Cite
Fasching PA, Häberle L, Rack B, et al. Clinical validation of genetic variants associated with . Oncotarget. 2017;8(44):78133-78143doi: 10.18632/oncotarget.17726.
Fasching, P. A., Häberle, L., Rack, B., Li, L., Hein, A., Ekici, A. B., Reis, A., Lux, M. P., Cunningham, J. M., Ruebner, M., Jenkins, G., Fridley, B., Schneeweiss, A., Tesch, H., Lichtenegger, W., Fehm, T., Heinrich, G., Rezai, M., Beckmann, M. W., Janni, W., Weinshilboum, R. M., & Wang, L. (2017). Clinical validation of genetic variants associated with . Oncotarget, 8(44), 78133-78143. https://doi.org/10.18632/oncotarget.17726
Fasching, Peter A, et al. "Clinical validation of genetic variants associated with ." Oncotarget vol. 8,44 (2017): 78133-78143. doi: https://doi.org/10.18632/oncotarget.17726
Fasching PA, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, Lux MP, Cunningham JM, Ruebner M, Jenkins G, Fridley B, Schneeweiss A, Tesch H, Lichtenegger W, Fehm T, Heinrich G, Rezai M, Beckmann MW, Janni W, Weinshilboum RM, Wang L. Clinical validation of genetic variants associated with . Oncotarget. 2017 May 09;8(44):78133-78143. doi: 10.18632/oncotarget.17726. eCollection 2017 Sep 29. PMID: 29100455; PMCID: PMC5652844.
Copy Download .nbib Format: NLM
Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention.

Geburtshilfe und Frauenheilkunde

Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Wöckel A, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wallwiener D, Brucker SY, Schütz F, Fasching PA, Fehm TN.
PMID: 29576630
Geburtshilfe Frauenheilkd. 2018 Mar;78(3):246-259. doi: 10.1055/s-0044-101614. Epub 2018 Mar 21.

The treatment of metastatic breast cancer has become more complicated due to increasing numbers of new therapies which need to be tested. Therapies are now being developed to treat special clinical or molecular subgroups. Even though intrinsic molecular subtypes...

Cite
Schneeweiss A, Lux MP, Janni W, et al. Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. Geburtshilfe Frauenheilkd. 2018;78(3):246-259doi: 10.1055/s-0044-101614.
Schneeweiss, A., Lux, M. P., Janni, W., Hartkopf, A. D., Nabieva, N., Taran, F. A., Overkamp, F., Kolberg, H. C., Hadji, P., Tesch, H., Wöckel, A., Ettl, J., Lüftner, D., Wallwiener, M., Müller, V., Beckmann, M. W., Belleville, E., Wallwiener, D., Brucker, S. Y., Schütz, F., Fasching, P. A., & Fehm, T. N. (2018). Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. Geburtshilfe und Frauenheilkunde, 78(3), 246-259. https://doi.org/10.1055/s-0044-101614
Schneeweiss, Andreas, et al. "Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention." Geburtshilfe und Frauenheilkunde vol. 78,3 (2018): 246-259. doi: https://doi.org/10.1055/s-0044-101614
Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Wöckel A, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wallwiener D, Brucker SY, Schütz F, Fasching PA, Fehm TN. Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. Geburtshilfe Frauenheilkd. 2018 Mar;78(3):246-259. doi: 10.1055/s-0044-101614. Epub 2018 Mar 21. PMID: 29576630; PMCID: PMC5862553.
Copy Download .nbib Format: NLM
Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study.

Geburtshilfe und Frauenheilkunde

Fasching PA, Fehm T, Kellner S, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Würstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauß T, Thomssen C, Kümmel S, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Wallwiener D, Grischke EM, Beckmann MW, Brucker SY.
PMID: 25568468
Geburtshilfe Frauenheilkd. 2014 Dec;74(12):1137-1143. doi: 10.1055/s-0034-1383401.

No abstract available.

Cite
Fasching PA, Fehm T, Kellner S, et al. Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study. Geburtshilfe Frauenheilkd. 2014;74(12):1137-1143doi: 10.1055/s-0034-1383401.
Fasching, P. A., Fehm, T., Kellner, S., de Waal, J., Rezai, M., Baier, B., Baake, G., Kolberg, H. C., Guggenberger, M., Warm, M., Harbeck, N., Würstlein, R., Deuker, J. U., Dall, P., Richter, B., Wachsmann, G., Brucker, C., Siebers, J. W., Fersis, N., Kuhn, T., Wolf, C., Vollert, H. W., Breitbach, G. P., Janni, W., Landthaler, R., Kohls, A., Rezek, D., Noesslet, T., Fischer, G., Henschen, S., Praetz, T., Heyl, V., Kühn, T., Krauß, T., Thomssen, C., Kümmel, S., Hohn, A., Tesch, H., Mundhenke, C., Hein, A., Rauh, C., Bayer, C. M., Jacob, A., Schmidt, K., Belleville, E., Hadji, P., Wallwiener, D., Grischke, E. M., Beckmann, M. W., & Brucker, S. Y. (2014). Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study. Geburtshilfe und Frauenheilkunde, 74(12), 1137-1143. https://doi.org/10.1055/s-0034-1383401
Fasching, P A, et al. "Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study." Geburtshilfe und Frauenheilkunde vol. 74,12 (2014): 1137-1143. doi: https://doi.org/10.1055/s-0034-1383401
Fasching PA, Fehm T, Kellner S, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Würstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauß T, Thomssen C, Kümmel S, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Wallwiener D, Grischke EM, Beckmann MW, Brucker SY. Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study. Geburtshilfe Frauenheilkd. 2014 Dec;74(12):1137-1143. doi: 10.1055/s-0034-1383401. PMID: 25568468; PMCID: PMC4275317.
Copy Download .nbib Format: NLM
Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se.

Geburtshilfe und Frauenheilkunde

Schulz-Wendtland R, Bani M, Lux MP, Schwab S, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Fasching PA, Adamietz B, Meier-Meitinger M.
PMID: 25298545
Geburtshilfe Frauenheilkd. 2012 May;72(5):408-411. doi: 10.1055/s-0031-1298158.

No abstract available.

Cite
Schulz-Wendtland R, Bani M, Lux MP, et al. Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se. Geburtshilfe Frauenheilkd. 2012;72(5):408-411doi: 10.1055/s-0031-1298158.
Schulz-Wendtland, R., Bani, M., Lux, M. P., Schwab, S., Loehberg, C. R., Jud, S. M., Rauh, C., Bayer, C. M., Beckmann, M. W., Uder, M., Fasching, P. A., Adamietz, B., & Meier-Meitinger, M. (2012). Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se. Geburtshilfe und Frauenheilkunde, 72(5), 408-411. https://doi.org/10.1055/s-0031-1298158
Schulz-Wendtland, R, et al. "Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se." Geburtshilfe und Frauenheilkunde vol. 72,5 (2012): 408-411. doi: https://doi.org/10.1055/s-0031-1298158
Schulz-Wendtland R, Bani M, Lux MP, Schwab S, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Fasching PA, Adamietz B, Meier-Meitinger M. Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se. Geburtshilfe Frauenheilkd. 2012 May;72(5):408-411. doi: 10.1055/s-0031-1298158. PMID: 25298545; PMCID: PMC4168403.
Copy Download .nbib Format: NLM
From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples.

Frontiers in pharmacology

Facchini G, Della Pepa C, Cavaliere C, Cecere SC, Di Napoli M, D'Aniello C, Crispo A, Iovane G, Maiolino P, Tramontano T, Piscitelli R, Pisconti S, Montella M, Berretta M, Sorrentino D, Perdonà S, Pignata S.
PMID: 27199753
Front Pharmacol. 2016 May 03;7:110. doi: 10.3389/fphar.2016.00110. eCollection 2016.

BACKGROUND: The efficacy of Vinflunine, after failure of platinum-based chemotherapy in patients with metastatic or recurrent Transitional Cell Cancer of the Urothelial Tract, TCCU, has been demonstrated in an international, randomized, phase III trial comparing Vinflunine plus Best Supportive...

Cite
Facchini G, Della Pepa C, Cavaliere C, et al. From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples. Front Pharmacol. 2016;7:110doi: 10.3389/fphar.2016.00110.
Facchini, G., Della Pepa, C., Cavaliere, C., Cecere, S. C., Di Napoli, M., D'Aniello, C., Crispo, A., Iovane, G., Maiolino, P., Tramontano, T., Piscitelli, R., Pisconti, S., Montella, M., Berretta, M., Sorrentino, D., Perdonà, S., & Pignata, S. (2016). From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples. Frontiers in pharmacology, 7110. https://doi.org/10.3389/fphar.2016.00110
Facchini, Gaetano, et al. "From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples." Frontiers in pharmacology vol. 7 (2016): 110. doi: https://doi.org/10.3389/fphar.2016.00110
Facchini G, Della Pepa C, Cavaliere C, Cecere SC, Di Napoli M, D'Aniello C, Crispo A, Iovane G, Maiolino P, Tramontano T, Piscitelli R, Pisconti S, Montella M, Berretta M, Sorrentino D, Perdonà S, Pignata S. From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples. Front Pharmacol. 2016 May 03;7:110. doi: 10.3389/fphar.2016.00110. eCollection 2016. PMID: 27199753; PMCID: PMC4853416.
Copy Download .nbib Format: NLM
Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills.

Geburtshilfe und Frauenheilkunde

Graf J, Simoes E, Wißlicen K, Rava L, Walter CB, Hartkopf A, Keilmann L, Taran A, Wallwiener S, Fasching P, Brucker SY, Wallwiener M.
PMID: 27239062
Geburtshilfe Frauenheilkd. 2016 May;76(5):535-541. doi: 10.1055/s-0042-105872.

No abstract available.

Cite
Graf J, Simoes E, Wißlicen K, et al. Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills. Geburtshilfe Frauenheilkd. 2016;76(5):535-541doi: 10.1055/s-0042-105872.
Graf, J., Simoes, E., Wißlicen, K., Rava, L., Walter, C. B., Hartkopf, A., Keilmann, L., Taran, A., Wallwiener, S., Fasching, P., Brucker, S. Y., & Wallwiener, M. (2016). Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills. Geburtshilfe und Frauenheilkunde, 76(5), 535-541. https://doi.org/10.1055/s-0042-105872
Graf, J, et al. "Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills." Geburtshilfe und Frauenheilkunde vol. 76,5 (2016): 535-541. doi: https://doi.org/10.1055/s-0042-105872
Graf J, Simoes E, Wißlicen K, Rava L, Walter CB, Hartkopf A, Keilmann L, Taran A, Wallwiener S, Fasching P, Brucker SY, Wallwiener M. Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills. Geburtshilfe Frauenheilkd. 2016 May;76(5):535-541. doi: 10.1055/s-0042-105872. PMID: 27239062; PMCID: PMC4873300.
Copy Download .nbib Format: NLM
Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy.

Geburtshilfe und Frauenheilkunde

Schulz-Wendtland R, Dankerl P, Bani MR, Fasching PA, Heusinger K, Lux MP, Jud SM, Rauh C, Bayer CM, Schrauder MG, Beckmann MW, Uder M, Brehm B, Loehberg CR.
PMID: 28331239
Geburtshilfe Frauenheilkd. 2017 Feb;77(2):169-175. doi: 10.1055/s-0042-124191.

No abstract available.

Cite
Schulz-Wendtland R, Dankerl P, Bani MR, et al. Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy. Geburtshilfe Frauenheilkd. 2017;77(2):169-175doi: 10.1055/s-0042-124191.
Schulz-Wendtland, R., Dankerl, P., Bani, M. R., Fasching, P. A., Heusinger, K., Lux, M. P., Jud, S. M., Rauh, C., Bayer, C. M., Schrauder, M. G., Beckmann, M. W., Uder, M., Brehm, B., & Loehberg, C. R. (2017). Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy. Geburtshilfe und Frauenheilkunde, 77(2), 169-175. https://doi.org/10.1055/s-0042-124191
Schulz-Wendtland, R, et al. "Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy." Geburtshilfe und Frauenheilkunde vol. 77,2 (2017): 169-175. doi: https://doi.org/10.1055/s-0042-124191
Schulz-Wendtland R, Dankerl P, Bani MR, Fasching PA, Heusinger K, Lux MP, Jud SM, Rauh C, Bayer CM, Schrauder MG, Beckmann MW, Uder M, Brehm B, Loehberg CR. Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy. Geburtshilfe Frauenheilkd. 2017 Feb;77(2):169-175. doi: 10.1055/s-0042-124191. PMID: 28331239; PMCID: PMC5357217.
Copy Download .nbib Format: NLM
[Attempted early prognostic judgment in myocardial infarct. I. Evaluation of the clinical symptoms].

Giornale di gerontologia

CUSSINI G, VANCINI B, FACCHINI G, PINELLI G.
PMID: 13813431
G Gerontol. 1960 Apr;8:269-73.

No abstract available.

Cite
CUSSINI G, VANCINI B, FACCHINI G, et al. [Attempted early prognostic judgment in myocardial infarct. I. Evaluation of the clinical symptoms]. G Gerontol. 1960;8:269-73
CUSSINI, G., VANCINI, B., FACCHINI, G., & PINELLI, G. (1960). [Attempted early prognostic judgment in myocardial infarct. I. Evaluation of the clinical symptoms]. Giornale di gerontologia, 8269-73.
CUSSINI, G, et al. "[Attempted early prognostic judgment in myocardial infarct. I. Evaluation of the clinical symptoms]." Giornale di gerontologia vol. 8 (1960): 269-73.
CUSSINI G, VANCINI B, FACCHINI G, PINELLI G. [Attempted early prognostic judgment in myocardial infarct. I. Evaluation of the clinical symptoms]. G Gerontol. 1960 Apr;8:269-73. Italian. PMID: 13813431.
Copy Download .nbib Format: NLM
Voltage-induced dependence of Raman-active modes in single-wall carbon nanotube thin films.

Nano letters

Fanchini G, Unalan HE, Chhowalla M.
PMID: 17394368
Nano Lett. 2007 May;7(5):1129-33. doi: 10.1021/nl062418m. Epub 2007 Mar 30.

We report on electrical Raman measurements in transparent and conducting single-wall carbon nanotube (SWNT) thin films. Application of external voltage results in downshifts of the D and G modes and in reduction of their intensity. The intensities of the...

Cite
Fanchini G, Unalan HE, Chhowalla M. Voltage-induced dependence of Raman-active modes in single-wall carbon nanotube thin films. Nano Lett. 2007;7(5):1129-33doi: 10.1021/nl062418m.
Fanchini, G., Unalan, H. E., & Chhowalla, M. (2007). Voltage-induced dependence of Raman-active modes in single-wall carbon nanotube thin films. Nano letters, 7(5), 1129-33. https://doi.org/10.1021/nl062418m
Fanchini, Giovanni, et al. "Voltage-induced dependence of Raman-active modes in single-wall carbon nanotube thin films." Nano letters vol. 7,5 (2007): 1129-33. doi: https://doi.org/10.1021/nl062418m
Fanchini G, Unalan HE, Chhowalla M. Voltage-induced dependence of Raman-active modes in single-wall carbon nanotube thin films. Nano Lett. 2007 May;7(5):1129-33. doi: 10.1021/nl062418m. Epub 2007 Mar 30. PMID: 17394368.
Copy Download .nbib Format: NLM
Update on Anti-EGFR Therapy.

Journal of oncology

Chua D, Fasching P, Ma B, Thongprasert S, Wirth L.
PMID: 19750187
J Oncol. 2009;2009:157964. doi: 10.1155/2009/157964. Epub 2009 Sep 10.

No abstract available.

Cite
Chua D, Fasching P, Ma B, et al. Update on Anti-EGFR Therapy. J Oncol. 2009;2009:157964doi: 10.1155/2009/157964.
Chua, D., Fasching, P., Ma, B., Thongprasert, S., & Wirth, L. (2009). Update on Anti-EGFR Therapy. Journal of oncology, 2009157964. https://doi.org/10.1155/2009/157964
Chua, Daniel, et al. "Update on Anti-EGFR Therapy." Journal of oncology vol. 2009 (2009): 157964. doi: https://doi.org/10.1155/2009/157964
Chua D, Fasching P, Ma B, Thongprasert S, Wirth L. Update on Anti-EGFR Therapy. J Oncol. 2009;2009:157964. doi: 10.1155/2009/157964. Epub 2009 Sep 10. PMID: 19750187; PMCID: PMC2740841.
Copy Download .nbib Format: NLM
Active photonic crystal terahertz laser.

Optics express

Benz A, Deutsch Ch, Fasching G, Unterrainer K, Andrews AM, Klang P, Schrenk W, Strasser G.
PMID: 19158909
Opt Express. 2009 Jan 19;17(2):941-6. doi: 10.1364/oe.17.000941.

We present the design and the realization of active photonic crystal (PhC) semiconductor lasers. The PhC consists of semiconductor nanostructure pillars which provide gain at a quantized transition energy. The vertical layer sequence is that of a terahertz quantum...

Cite
Benz A, Deutsch Ch, Fasching G, et al. Active photonic crystal terahertz laser. Opt Express. 2009;17(2):941-6doi: 10.1364/oe.17.000941.
Benz, A., Deutsch, C. h., Fasching, G., Unterrainer, K., Andrews, A. M., Klang, P., Schrenk, W., & Strasser, G. (2009). Active photonic crystal terahertz laser. Optics express, 17(2), 941-6. https://doi.org/10.1364/oe.17.000941
Benz, A, et al. "Active photonic crystal terahertz laser." Optics express vol. 17,2 (2009): 941-6. doi: https://doi.org/10.1364/oe.17.000941
Benz A, Deutsch Ch, Fasching G, Unterrainer K, Andrews AM, Klang P, Schrenk W, Strasser G. Active photonic crystal terahertz laser. Opt Express. 2009 Jan 19;17(2):941-6. doi: 10.1364/oe.17.000941. PMID: 19158909.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 369 entries